If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIAP.L Regulatory News (IAP)

  • There is currently no data for IAP

ICAP launches ISDX

31 Oct 2012 10:00

RNS Number : 9417P
ICAP PLC
31 October 2012
 



ICAP launches ICAP Securities & Derivatives Exchange (ISDX)

the new small and mid cap equity listings venue for SMEs

 

London, 31 October 2012 - ICAP (IAP.L), the world's leading interdealer broker and provider of post trade risk and information services, today announces the launch of ICAP Securities & Derivatives Exchange (ISDX), the listing venue for small and medium sized enterprises seeking access to equity capital to finance and grow their businesses.

 

This launch and rebranding follows ICAP's purchase of PLUS Stock Exchange plc on 21 June when ICAP committed to supporting and expanding the listings venue. At ICAP's offices in London today a number of ISDX companies will present to an audience of investors, advisors, market makers and other stakeholders. Companies presenting are Bioventix plc, Central Asian Minerals and Resources plc, Chapel Down Group plc, Daniel Thwaites plc, One Media iP Group plc, Quercus Publishing plc, Shepherd Neame Ltd and Sprue Aegis plc.

 

At the presentation ICAP will announce a series of initiatives which have been developed in close consultation with the market and draw on ICAP's extensive experience and expertise as a markets operator. These include:

 

·; the provision of increased liquidity to the market by the addition of two leading market makers, Peel Hunt and Shore Capital, which will make markets in ISDX's largest stocks to ensure the exchange operates as an orderly primary and secondary marketplace;

 

·; a focus on increasing the quality of the companies listed on the exchange, including the introduction of a new admissions framework in 2013, to ensure stricter common standards for companies joining ISDX and strengthen investor confidence; and

 

·; a new exchange website, www.isdx.com. This will provide real-time pricing information, news, account downloads and charting information and so allow companies to communicate more effectively with investors.

 

ISDX will allow companies to raise capital on the primary market and investors to trade shares in these companies on an active secondary market. The exchange will be a viable alternative listings venue to support the growth ambitions of SMEs, providing them with widespread exposure to their current and potential investors.

 

ICAP has established a new management team committed to the development and success of the exchange. This team is led by Seth Johnson CEO of ICAP Securities & Derivatives Exchangeand member of ICAP's Global Executive Management Group.

 

Michael Spencer, Group CEO of ICAP, said:"As someone who has founded and grown a business I know how important it is to be able to access development capital. I'm very pleased that ICAP is providing SMEs with a well-run and well-supported listings venue, with a clear and transparent route to market, to support their long-term growth ambitions. SMEs are vitally important to the UK economy and ICAP is committed to developing ISDX for the benefit of the whole business and financial community."

 

Seth Johnson, CEO of ICAP Securities & Derivatives Exchange, said: "The launch of ICAP Securities & Derivatives Exchange today is great news for smaller companies and their investors. Companies seeking to list will benefit from a clear and straightforward route to market. Investors will gain access to exciting growth opportunities and with market makers committed to providing liquidity, they will be able to trade these shares with confidence.

We are committed to the success of this exchange and as an experienced markets operator, ICAP has the right skills and knowledge to make this the venue of choice for SMEs seeking equity capital."

 

Peter Harrison, CEO of Bioventix said: "ICAP has demonstrated they are committed to the success of this exchange as an SME listing and trading venue, which will give companies like Bioventix widespread exposure and access to capital. Creating a strong primary and liquid secondary market is extremely welcome and we are delighted to be able to benefit from ICAP's vast markets expertise."

 

Paul Stevens, Fund Manager at Octopus Investments said: "This is an important and dynamic part of the equities market that investors want to access. The ability to trade these stocks with low transaction costs and immediacy of trading makes this a very attractive market to invest through. ICAP's commitment to this market and to providing a liquid secondary market will ensure investors can trade these stocks with confidence."

 

Nick Conyerd of Market Maker Shore Capital said: "We recognise there is investor demand to trade stocks on this exchange and are committed to providing liquidity. In creating ICAP Securities & Derivatives Exchange, ICAP has responded to the need for an SME equity market that can function effectively alongside new European Union regulations and we are looking forward to working with them to make this exchange a success."

 

Tim Ward, CEO of the Quoted Companies Alliance said:"There are nearly 2,000 small and mid-size quoted companies in the UK, representing 85% of all quoted companies. Access to capital is one of the most important issues for our members. The launch of ICAP Securities & Derivatives Exchange is great news for all such companies. They are the UK's engines of growth and their performance will drive our future economic success."

 

Contacts:

 

Serra Balls

Head of Public Relations

+44 (0) 20 7050 7124

Alex Dee

Head of Investor Relations

+44 (0) 20 7050 7123

Andy Donald

Maitland

+44 (0) 20 7379 5151

 

Notes to Editors:

 

About ICAPICAP is the world's leading interdealer broker and provider of post trade risk and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through our post trade risk and information services we help our customers manage and mitigate risks in their portfolios. For more information go to www.icap.com.

 

About ICAP Securities & Derivatives Exchange

ICAP Securities & Derivatives Exchange is a Recognised Investment Exchange (RIE) under the Financial Services & Markets Act 2000. It is an equity market for small and medium sized companies, who want to raise money from investors to finance and grow their businesses. ICAP acquired the RIE license through its purchase of PLUS Stock Exchange plc on 21 June 2012. For more information go to www.isdx.com.

 

About Seth Johnson

Seth Johnson joined ICAP's electronic markets in November 2011 to lead the expansion of its product portfolio. In this role he is the co-head of BrokerTec, ICAP's fixed income electronic trading platform, and the CEO of ICAP Securities & Derivatives Exchange.

 

Seth joined ICAP as a graduate trainee and has worked at the company for more than 20 years. For ten years, he was the Managing Director of the Interest Rates, Options and Inflation Swaps desks. He oversaw the introduction of new and innovative trading solutions, including the volume match system currently used by the ICAP Inflation and Options desks in London.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGCBDGSDXBGDB
Date   Source Headline
14th Feb 20112:10 pmRNSBlocklisting Interim Review
14th Feb 20112:10 pmRNSBlocklisting Interim Review
8th Feb 20113:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20117:00 amRNSInterim Management Statement
1st Feb 20114:15 pmRNSTotal Voting Rights
4th Jan 201111:54 amRNSTotal Voting Rights
7th Dec 20109:30 amRNSHolding(s) in Company
6th Dec 20106:09 pmRNSDirector/PDMR Shareholding
1st Dec 201012:33 pmRNSTotal Voting Rights
18th Nov 20109:30 amRNSDirectorate Change
17th Nov 20107:00 amRNSHalf Year Results to 30 September 2010
1st Nov 201012:00 pmRNSTotal Voting Rights
19th Oct 201011:30 amRNSHolding(s) in Company
15th Oct 20102:00 pmRNSICAP Announces Management Change
4th Oct 20103:00 pmRNSHolding(s) in Company
4th Oct 20108:00 amRNSICAP transfers treasury consultancy business
1st Oct 20104:30 pmRNSTotal Voting Rights
1st Oct 20103:00 pmRNSICAP Announces Retirement of Jim McNulty from ICAP
30th Sep 20107:00 amRNSICAP plc Trading Statement
22nd Sep 20104:50 pmRNSICAP Appoints Hsieh Fu Hua as a Non Exec. Director
14th Sep 20107:00 amRNSStatement re Post Trade Risk & Information Seminar
1st Sep 20101:15 pmRNSTotal Voting Rights
31st Aug 201012:00 pmRNSICAP to take Euro interest rate swaps electronic
20th Aug 20103:40 pmRNSDirector/PDMR Shareholding
19th Aug 20107:00 amRNSAdditional Listing
16th Aug 20104:30 pmRNSBlocklisting Interim Review
16th Aug 20104:30 pmRNSBlocklisting Interim Review
16th Aug 20104:30 pmRNSBlocklisting Interim Review
11th Aug 201011:29 amRNSScrip dividend shares and PDMR holding
2nd Aug 201011:14 amRNSTotal Voting Rights
28th Jul 201012:56 pmRNSScrip Dividend Scheme
14th Jul 20103:20 pmRNSResult of AGM
14th Jul 20103:20 pmRNSDirectorate Change
14th Jul 20107:00 amRNSFirst Quarter Interim Management Statement
2nd Jul 201012:00 pmRNSAnnual Information Update
1st Jul 20109:00 amRNSTotal Voting Rights
22nd Jun 20105:30 pmRNSTransaction in Own Shares
21st Jun 20105:53 pmRNSDirector/PDMR Shareholding
21st Jun 20105:53 pmRNSDirector/PDMR Shareholding
15th Jun 20105:30 pmRNSDirector/PDMR Shareholding
11th Jun 20103:41 pmRNSAnnual Financial Report
8th Jun 20107:00 amRNSTransaction in Own Shares
2nd Jun 20106:02 pmRNSDirector/PDMR Shareholding
2nd Jun 20107:00 amRNSTransaction in Own Shares
1st Jun 201010:45 amRNSTotal Voting Rights
28th May 20105:47 pmRNSTransaction in Own Shares
28th May 20105:30 pmRNSDirector/PDMR Shareholding
26th May 20106:13 pmRNSTransaction in Own Shares
26th May 20106:12 pmRNSDirector/PDMR Shareholding
21st May 20105:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.